{"count": 5, "results": [{"_id": "25516195", "pmid": 25516195, "title": "High-dose simvastatin for aneurysmal subarachnoid hemorrhage: multicenter randomized controlled double-blinded clinical trial.", "journal": "Stroke", "authors": ["Wong GK", "Chan DY", "Siu DY", "Zee BC", "Poon WS", "Chan MT", "Gin T", "Leung M", "HDS-SAH Investigators"], "date": "2015-02-01T00:00:00Z", "doi": "10.1161/STROKEAHA.114.007006", "meta_date_publication": "2015 Feb", "meta_volume": "46", "meta_issue": "2", "meta_pages": "382-8", "score": 50056.91, "text_hl": "We hypothesized that a high dose of 80 mg of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ daily for 3 weeks would reduce the incidence of delayed @<m>DISEASE_Attention_Deficit_Disorder_with_Hyperactivity</m> @DISEASE_MESH:D001289 @@@ischemic deficits@@@ after @DISEASE_Subarachnoid_Hemorrhage @DISEASE_MESH:D013345 @@@subarachnoid hemorrhage@@@ compared with a lower dose (40 mg of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ daily) and lead to improved clinical outcomes. ", "citations": {"NLM": "Wong GK, Chan DY, Siu DY, Zee BC, Poon WS, Chan MT, Gin T, Leung M, HDS-SAH Investigators. High-dose simvastatin for aneurysmal subarachnoid hemorrhage: multicenter randomized controlled double-blinded clinical trial. Stroke. 2015 Feb;46(2):382-8. PMID: 25516195", "BibTeX": "@article{25516195, title={High-dose simvastatin for aneurysmal subarachnoid hemorrhage: multicenter randomized controlled double-blinded clinical trial.}, author={Wong GK and Chan DY and Siu DY and Zee BC and Poon WS and Chan MT and Gin T and Leung M and HDS-SAH Investigators}, journal={Stroke}, volume={46}, number={2}, pages={382-8}}"}}, {"_id": "23392270", "pmid": 23392270, "title": "High-dose simvastatin for aneurysmal subarachnoid hemorrhage: a multicenter, randomized, controlled, double-blind clinical trial protocol.", "journal": "Neurosurgery", "authors": ["Wong GK", "Liang M", "Tan H", "Lee MW", "Po YC", "Chan KY", "Poon WS"], "date": "2013-05-01T00:00:00Z", "doi": "10.1227/NEU.0b013e31828ab413", "meta_date_publication": "2013 May", "meta_volume": "72", "meta_issue": "5", "meta_pages": "840-4", "score": 50053.26, "text_hl": "OBJECTIVE: To determine whether 80 mg @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ daily (high dose) over 3 weeks initiated within 96 hours of the ictus will reduce the incidence of delayed @<m>DISEASE_Attention_Deficit_Disorder_with_Hyperactivity</m> @DISEASE_MESH:D001289 @@@ischemic deficits@@@ after @DISEASE_Subarachnoid_Hemorrhage @DISEASE_MESH:D013345 @@@subarachnoid hemorrhage@@@ compared with 40 mg @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ daily (normal dose), leading to improvements in clinical outcomes and thus cost-effectiveness. ", "citations": {"NLM": "Wong GK, Liang M, Tan H, Lee MW, Po YC, Chan KY, Poon WS. High-dose simvastatin for aneurysmal subarachnoid hemorrhage: a multicenter, randomized, controlled, double-blind clinical trial protocol. Neurosurgery. 2013 May;72(5):840-4. PMID: 23392270", "BibTeX": "@article{23392270, title={High-dose simvastatin for aneurysmal subarachnoid hemorrhage: a multicenter, randomized, controlled, double-blind clinical trial protocol.}, author={Wong GK and Liang M and Tan H and Lee MW and Po YC and Chan KY and Poon WS}, journal={Neurosurgery}, volume={72}, number={5}, pages={840-4}}"}}, {"_id": "16051891", "pmid": 16051891, "title": "Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial.", "journal": "Stroke", "authors": ["Lynch JR", "Wang H", "McGirt MJ", "Floyd J", "Friedman AH", "Coon AL", "Blessing R", "Alexander MJ", "Graffagnino C", "Warner DS", "Laskowitz DT"], "date": "2005-09-01T00:00:00Z", "doi": "10.1161/01.STR.0000177879.11607.10", "meta_date_publication": "2005 Sep", "meta_volume": "36", "meta_issue": "9", "meta_pages": "2024-6", "score": 50052.844, "text_hl": "Highest mean middle cerebral artery transcranial Doppler velocities were significantly lower in the @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@-treated group (103+/-41 versus 149+/-47; P<0.01). ", "citations": {"NLM": "Lynch JR, Wang H, McGirt MJ, Floyd J, Friedman AH, Coon AL, Blessing R, Alexander MJ, Graffagnino C, Warner DS, Laskowitz DT. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke. 2005 Sep;36(9):2024-6. PMID: 16051891", "BibTeX": "@article{16051891, title={Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial.}, author={Lynch JR and Wang H and McGirt MJ and Floyd J and Friedman AH and Coon AL and Blessing R and Alexander MJ and Graffagnino C and Warner DS and Laskowitz DT}, journal={Stroke}, volume={36}, number={9}, pages={2024-6}}"}}, {"_id": "29434767", "pmid": 29434767, "pmcid": "PMC5776644", "title": "Simvastatin inhibits the apoptosis of hippocampal cells in a mouse model of Alzheimer's disease", "journal": "Exp Ther Med", "authors": ["Hu X", "Song C", "Fang M", "Li C"], "date": "2018-02-01T00:00:00Z", "doi": "10.3892/etm.2017.5620", "meta_date_publication": "2018 Feb", "meta_volume": "15", "meta_issue": "2", "meta_pages": "1795-1802", "score": 50050.008, "text_hl": "Furthermore, treatment with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ improved the @DISEASE_Dementia @DISEASE_MESH:D003704 @@@dementia@@@ status of 3xTg-@DISEASE_Alzheimer_Disease @DISEASE_MESH:D000544 @@@AD@@@ @SPECIES_10090 @@@mice@@@, as determined by a learning task in which @SPECIES_10090 @@@mice@@@ exhibited significantly reduced @<m>DISEASE_Attention_Deficit_Disorder_with_Hyperactivity</m> @DISEASE_MESH:D001289 @@@attention impairment@@@, @DISEASE_Disruptive_Impulse_Control_and_Conduct_Disorders @DISEASE_MESH:D007174 @@@impulsivity@@@ and compulsivity (P<0.01). ", "citations": {"NLM": "Hu X, Song C, Fang M, Li C. Simvastatin inhibits the apoptosis of hippocampal cells in a mouse model of Alzheimer's disease Exp Ther Med. 2018 Feb;15(2):1795-1802. PMID: 29434767", "BibTeX": "@article{29434767, title={Simvastatin inhibits the apoptosis of hippocampal cells in a mouse model of Alzheimer's disease}, author={Hu X and Song C and Fang M and Li C}, journal={Exp Ther Med}, volume={15}, number={2}, pages={1795-1802}}"}}, {"_id": "24090588", "pmid": 24090588, "title": "Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial.", "journal": "Lancet Neurol", "authors": ["van der Vaart T", "Plasschaert E", "Rietman AB", "Renard M", "Oostenbrink R", "Vogels A", "de Wit MC", "Descheemaeker MJ", "Vergouwe Y", "Catsman-Berrevoets CE", "Legius E", "Elgersma Y", "Moll HA"], "date": "2013-11-01T00:00:00Z", "doi": "10.1016/S1474-4422(13)70227-8", "meta_date_publication": "2013 Nov", "meta_volume": "12", "meta_issue": "11", "meta_pages": "1076-83", "score": 50046.12, "text_hl": "We did not assess outcomes in two @SPECIES_9606 @@@patients@@@ in the placebo group because they needed additional drug therapy. @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ for 12 months had no effect on full-scale intelligence (treatment effect compared with placebo -1 3 IQ points [95% CI -3 8 to 1 3]; p=0 33), @<m>DISEASE_Attention_Deficit_Disorder_with_Hyperactivity</m> @DISEASE_MESH:D001289 @@@attention problems@@@ (-1 6 T-score points [-4 3 to 1 0]; p=0 23), and internalising @DISEASE_Alcohol_Related_Disorders @DISEASE_MESH:D019973 @@@behavioural problems@@@ (-0 1 T-score points [-3 3 to 3 1]; p=0 96). 38 (88%) of 43 @SPECIES_9606 @@@patients@@@ on @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and 39 (95%) of 41 @SPECIES_9606 @@@patients@@@ on placebo reported adverse events, which were serious in two and four @SPECIES_9606 @@@patients@@@, respectively. ", "citations": {"NLM": "van der Vaart T, Plasschaert E, Rietman AB, Renard M, Oostenbrink R, Vogels A, de Wit MC, Descheemaeker MJ, Vergouwe Y, Catsman-Berrevoets CE, Legius E, Elgersma Y, Moll HA. Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial. Lancet Neurol. 2013 Nov;12(11):1076-83. PMID: 24090588", "BibTeX": "@article{24090588, title={Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial.}, author={van der Vaart T and Plasschaert E and Rietman AB and Renard M and Oostenbrink R and Vogels A and de Wit MC and Descheemaeker MJ and Vergouwe Y and Catsman-Berrevoets CE and Legius E and Elgersma Y and Moll HA}, journal={Lancet Neurol}, volume={12}, number={11}, pages={1076-83}}"}}]}